160 related articles for article (PubMed ID: 10712599)
1. Degradation of transcription factor IRF-1 by the ubiquitin-proteasome pathway. The C-terminal region governs the protein stability.
Nakagawa K; Yokosawa H
Eur J Biochem; 2000 Mar; 267(6):1680-6. PubMed ID: 10712599
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system.
Sasajima H; Nakagawa K; Yokosawa H
Eur J Biochem; 2002 Jul; 269(14):3596-604. PubMed ID: 12135500
[TBL] [Abstract][Full Text] [Related]
3. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation.
Lin R; Heylbroeck C; Pitha PM; Hiscott J
Mol Cell Biol; 1998 May; 18(5):2986-96. PubMed ID: 9566918
[TBL] [Abstract][Full Text] [Related]
4. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.
Gregory MA; Hann SR
Mol Cell Biol; 2000 Apr; 20(7):2423-35. PubMed ID: 10713166
[TBL] [Abstract][Full Text] [Related]
5. Direct demonstration of rapid degradation of nuclear sterol regulatory element-binding proteins by the ubiquitin-proteasome pathway.
Hirano Y; Yoshida M; Shimizu M; Sato R
J Biol Chem; 2001 Sep; 276(39):36431-7. PubMed ID: 11477106
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
[TBL] [Abstract][Full Text] [Related]
7. Degradation of proto-oncoprotein c-Rel by the ubiquitin-proteasome pathway.
Chen E; Hrdlickova R; Nehyba J; Longo DL; Bose HR; Li CC
J Biol Chem; 1998 Dec; 273(52):35201-7. PubMed ID: 9857058
[TBL] [Abstract][Full Text] [Related]
8. Interplay between repressing and activating domains defines the transcriptional activity of IRF-1.
Kirchhoff S; Oumard A; Nourbakhsh M; Levi BZ; Hauser H
Eur J Biochem; 2000 Dec; 267(23):6753-61. PubMed ID: 11082185
[TBL] [Abstract][Full Text] [Related]
9. Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins.
Hateboer G; Kerkhoven RM; Shvarts A; Bernards R; Beijersbergen RL
Genes Dev; 1996 Dec; 10(23):2960-70. PubMed ID: 8956997
[TBL] [Abstract][Full Text] [Related]
10. COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from post-Golgi compartments.
Benharouga M; Haardt M; Kartner N; Lukacs GL
J Cell Biol; 2001 May; 153(5):957-70. PubMed ID: 11381082
[TBL] [Abstract][Full Text] [Related]
11. A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit.
Lin L; Ghosh S
Mol Cell Biol; 1996 May; 16(5):2248-54. PubMed ID: 8628291
[TBL] [Abstract][Full Text] [Related]
12. Degradation of the Id2 developmental regulator: targeting via N-terminal ubiquitination.
Fajerman I; Schwartz AL; Ciechanover A
Biochem Biophys Res Commun; 2004 Feb; 314(2):505-12. PubMed ID: 14733935
[TBL] [Abstract][Full Text] [Related]
13. Regulatory domain of protein stability of human P51/TAP63, a P53 homologue.
Osada M; Inaba R; Shinohara H; Hagiwara M; Nakamura M; Ikawa Y
Biochem Biophys Res Commun; 2001 May; 283(5):1135-41. PubMed ID: 11355891
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
Tanimoto K; Makino Y; Pereira T; Poellinger L
EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113
[TBL] [Abstract][Full Text] [Related]
15. Degradation of CFTR by the ubiquitin-proteasome pathway.
Ward CL; Omura S; Kopito RR
Cell; 1995 Oct; 83(1):121-7. PubMed ID: 7553863
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes.
Boudjelal M; Wang Z; Voorhees JJ; Fisher GJ
Cancer Res; 2000 Apr; 60(8):2247-52. PubMed ID: 10786691
[TBL] [Abstract][Full Text] [Related]
17. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.
Huang LE; Gu J; Schau M; Bunn HF
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):7987-92. PubMed ID: 9653127
[TBL] [Abstract][Full Text] [Related]
18. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein.
Campanero MR; Flemington EK
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2221-6. PubMed ID: 9122175
[TBL] [Abstract][Full Text] [Related]
19. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway.
Kim TK; Maniatis T
Science; 1996 Sep; 273(5282):1717-9. PubMed ID: 8781235
[TBL] [Abstract][Full Text] [Related]
20. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells.
Dantuma NP; Lindsten K; Glas R; Jellne M; Masucci MG
Nat Biotechnol; 2000 May; 18(5):538-43. PubMed ID: 10802622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
